کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
6197747 1261941 2016 8 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Prevalence and severity of dry eye in candidates for laser in situ keratomileusis for myopia in Russia
موضوعات مرتبط
علوم پزشکی و سلامت پزشکی و دندانپزشکی چشم پزشکی
پیش نمایش صفحه اول مقاله
Prevalence and severity of dry eye in candidates for laser in situ keratomileusis for myopia in Russia
چکیده انگلیسی

PurposeTo assess the prevalence and severity of dry-eye disease in patients with myopia being evaluated for laser in situ keratomileusis.SettingNine ophthalmology centers in Russia.DesignProspective noninterventional cross-sectional study.MethodsThe assessments included the Schirmer I test, tear breakup time (TBUT), lissamine green and fluorescein staining (Oxford grading scheme), Ocular Surface Disease Index (OSDI) questionnaire, and Dry Eye Workshop (DEWS) dry-eye severity grading.ResultsThe study comprised 400 patients with myopia (mean age 29.7 years); 145 (36.2%) wore contact lenses, and 81 (20.2%) used topical dry-eye medication. The mean Schirmer test score was 15.2 mm; 36.5% of patients had evidence of tear-volume deficiency (Schirmer score ≤10 mm). The mean TBUT was 11.7 seconds; 10.1% of patients had tear-film instability (TBUT <5 seconds). Conjunctival (lissamine green) staining intensity was categorized as minimal or greater (grade ≥1) in 62.3% of patients and mild or greater (grade ≥2) in 22.8% of patients. The mean OSDI score was 20.4, indicating mild ocular disability. Dry-eye severity (DEWS grading) was mild/episodic in 66.2%, moderate in 29.5%, and severe in 4.3% of patients. No clear correlation was evident between the Schirmer/TBUT scores and the lissamine green/OSDI scores.ConclusionsThe prevalence of dry eye in this population was estimated at approximately 10% to 40% (based on clinical signs) and 40% to 55% (based on symptoms); dry-eye severity was predominantly mild/episodic. The proportion of patients requiring dry-eye therapy (based on OSDI and DEWS severity findings) was almost 2 times higher than the proportion receiving treatment.Financial DisclosureDr. Maychuk has received research funding from Allergan CIS SARL.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Journal of Cataract & Refractive Surgery - Volume 42, Issue 3, March 2016, Pages 427-434
نویسندگان
, , ,